Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1990-05-03
1991-05-21
Rollins, John W.
Drug, bio-affecting and body treating compositions
Lymphokine
604 52, 604 53, A61K 31745, A61M 3100
Patent
active
050173707
ABSTRACT:
In accordance with the present invention, a method is provided for improving angioplasty procedures by reducing tissue damage during the procedure comprising infusing certain ethylene oxide-propylene oxide condensation surface-active copolymers before, during and/or after the angioplasty procedure.
The surface-active copolymer can be an ethylene oxide-propylene oxide condensation product with the following general formula:
REFERENCES:
patent: 2674619 (1954-04-01), Lundsted
patent: 2854378 (1958-09-01), Buckwalter et al.
patent: 3089818 (1963-05-01), Stone
patent: 3140232 (1964-07-01), Noseworthy
patent: 3450502 (1980-06-01), Hymes
patent: 3577522 (1971-05-01), Hymes
patent: 3590125 (1971-06-01), Hymes
patent: 3641240 (1972-02-01), Hymes et al.
patent: 3740421 (1973-06-01), Schmolka
patent: 3867521 (1975-02-01), Miskel et al.
patent: 3956259 (1976-05-01), Garcia et al.
patent: 3980772 (1976-09-01), Ginger et al.
patent: 4073886 (1978-02-01), Kohm
patent: 4100271 (1978-07-01), Kreszanoski
patent: 4179337 (1979-12-01), Davis et al.
patent: 4186253 (1980-01-01), Yokoyama et al.
patent: 4305922 (1981-12-01), Rhodes
patent: 4395393 (1983-07-01), Schmolka
patent: 4407790 (1983-10-01), Oakes et al.
patent: 4600652 (1986-07-01), Solomon et al.
patent: 4609546 (1986-09-01), Hiratani
Schmolka, I., "A Review of Block Polymer Surfactants", Journal of The American Oil Chemists Society, 54, No. 3, pp. 110-116 (1977).
Block and Graft Copolymerization, vol. 2 (ed. by R. J. Ceresa, John Wiley & Sons, 1976), "The Application of Block Copolymer Polyol Surfactants", L. G. Lundsted and I. R. Schmolka; pp. 174 through 205 and pp. 255 through 272 (references).
Reindorf, C. A., "Perfluorocarbon Compounds: Effects on the Rheological Properties of Sickle Erythrocytes in vitro", American Journal of Hematology, vol. 19, pp. 229-236 (1985).
Vercellotte, G. M., "Activation of Plasma Complement by Perfluorocarbon Artificial Blood: Probable Mechanism of Adverse Pulmonary Reactions in Treated Patients and Rationale for Corticosteroid Prophylaxis", Blood, vol. 59, pp. 1299-1304 (1982).
Rodeheaver, G. T., "Pluronic F-68: A Promising New Skin Wound Cleanser", Ann Emerg Med, 9:11, pp. 572-576 (1980).
Padilla, F. et al., "Effect of Fluorocarbon emulsions on the mechanical fragility of normal and sickle cells: in vitro stidues", Federation Proceedings, vol. 34, pp. 1510-1512 (1975).
Janoff, A. S. et al., "The Modification of Human Erythrocyte Membrane Structure by Membrane Stabilizers: An Electro Spin Resonance Study", American Journal of Hematology, vol. 10, pp. 171-179 (1981).
Moore, A. R. et al, "Reduction of Splenic Vascular Resistance During Profusion by Pluronic F.noteq.68", Journal of Surgical Research, vol. 8, No. 12, pp. 563-566 (1968).
Benner, K. U. et al, "Cold-Induced Platelet Aggregation in Vivo and its Inhibition by a Nonionic Surface Active Substance", Thrombosis Research, vol. 2, pp. 331-342 (1973).
Humes, A. C. et al, "The Influence of an Industrial Surfactant Pluronic F-68, in the Treatment of Hemorrhagic Shock", Journal of Surgical Research, vol. 11, pp. 191-197 (1971).
Hoie, J. et al, "Effects of Pluronic F68, Poloralkol, On Vascular Resistance in Vivo", Journal of Surgical Research, vol. 11, pp. 515-517 (1971).
Grover, F. L. et al, "A Nonionic Surfactant and Blood Viscosity", Arch. Surg., vol. 106, pp. 307-310 (1973).
Grover, F. L. et al, "The Effect of Pluronic F-68 On Circulatory Dynamics and Renal and Carotid Artery Flow During Hemorrhagic Shock", Journal of Surgical Research, vol. 17, pp. 30-35 (1974).
Ketchum, L. D. et al, "Pharmacological alterations in the clotting mechanism: Use in microvascular surgery", Journal of Hand Surgery, vol. 3, pp. 407-415 (1978).
Ketchum, Lynn D. et al, "Experimental Use of Pluronic.RTM. F-68 in Microvascular Surgery", Plastic and Reconstructive Surgery, vol. 53, pp. 288-292 (1974).
Vasco, K. A. et al., "Poloxalkol.RTM. (Pluronic F-68): A priming solution of cardiopulmonary bypass", Trans. Am. Soc. Artif. Int. Organs, 18, 526-531 (1972).
Block, N. L. et al., "Acutely traumatized canine ureter, Effects of low molecular weight dextran and surfactant Pluronic F-68", Urology, vol. III, 190-194 (1974).
Knize, D. M. et al, "Use of antisludging agents in experimental cold injuries", Surgery Gynecology & Obstetrics, vol. 129, pp. 1019-1026 (1969).
Gaehtgens et al., "Disaggregati of Human Red Blood Cells by Various Surface-Active Agents as Related to Changes of Cell Shape and Hemolysis", Act Heamat., vol. 33, pp. 82-89 (1975).
Smillie et al., "Cryopreservation of Human Platelets with Polyvinylpyrrolidone", Transfusion, vol. 21, pp. 552 through 556 (1981).
Organ Perfusion and Preservation (ed. by Norman, J. C., Appleton-Century-Crofts (1968)), Paton, B. C. et al., "The use of a nonionic detergent added ot organ perfusates", pp. 105 through 120.
Advances in Blood Substituted Research (ed. by Bolin et al., Alan R. Liss, Inc. New York (1983)), Sugi et al., The use of Fluosol-DA (FDA) in emergency situations: a report of 67 clinical cases, Abstract/451.
Technical bulletin entitled "Performance Chemicals".
Technical bulletin entitled "Pluronic.RTM. Block copolymer surfactants".
Perfluorochemical Blood Substitutes, Technical Information Ser. No. 5, Jun. 30, 1978, Manufacturer: The Green Cross Corporation.
The Patent Cooperation Treaty international search report for PCT patent application No. PCT/US87/01067.
Patent Cooperation Treaty International Search Report for the PCT Patent Application No. PCT/US87/01747.
Lane, T. A. et al., "Reduction in the toxicity of a component of an artificial blood substitute by supercritical fluid fractionation", Transfusion, vol. 28, pp. 375-378 (1987).
Lane, T. A. et al., "Paralysis of phagocyte migration due to an artificial blood substitute", Blood, vol. 64, pp. 400-405 (1984).
Spiess, B. D. et al., "Protection from cerebral air emboli with perfluorocarbons in rabbits", Stroke, vol. 17, pp. 1146-1149 (1986).
Kanter, K. R. et al., "Superiority of perfluorocarbon cardioplegia over blood or crystalloid cardioplegia", Circulation, vol. 64, pp. II-75, II-80 (1981).
Harjula, A. et al., "Perfluorocarbon solution as a myocardial preservati ve", J. Applied Cardiology, vol. 2, pp. 121-136 (1987).
Tokioka, M. D. et al., "Effects of intracoronary infusion of arterial blood or Fluosol-DA 20% on regional myocardial metabolism and function during brief coronary artery occlusions", Laboratory Investigation, vol. 75, pp. 473-481 (1987).
Benner, K. U. et al., "Uber die Wirkung von Pluronic.RTM. F68, einem polyoxypropylene-Polyoxyathylene-Kondensat, auf die ADP-induziert Thrombocytenaggregation in vitro", Pflugers Arch., vol. 315, pp. 45-52 (1970).
Forman, M. B. et al., "Reduction of infarct size with intracoronary perfluorochemical in a canine preparation of reperfusion", Circulation, vol. 71, pp. 1060-1068 (1985).
Forman, M. B. et al., "Beneficial long-term effect of intracoronary perfluorochemical on infarct size and ventricular function in a canine repersusion model", J. Am. Col. of Cardiol., pp. 1082-1090 (May 1987).
Goodman, R. L. et al., "Perfluorocarbon emulsions in cancer therapy: preliminary observations on presently available formulations", Int. J. Radiation Oncology Biol. Phys., vol. 10, pp. 1421-1424 (1984).
McBride, M. D. et al., "Restenois after successful coronary angioplasty", New Eng. J. Med., vol. 318, pp. 1734-1737 (1988).
Schwartz, L. et al., "Aspirin and dipyridamole in the prevention of restenosis after perccutaneous transluminal coronary angioplasty", New Eng. J. Med., vol. 318, pp. 1714-1719 (1988).
Hirzel, H. O. et al., "Short-and Long-term changes in myocardial perfusion after percutaneous transluminal coronary angioplasty assessed by thallium-201 exercise scintigraphy", Circulationvol. 63, pp. 1001-1007 (1981).
Duncan Alexander
Hunter Robert L.
Emory University
Rollins John W.
LandOfFree
Improved method of performing angioplasty procedures does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Improved method of performing angioplasty procedures, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Improved method of performing angioplasty procedures will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-236782